• Skip to main content
  • Skip to footer
  • Home
  • About
    • MyPE Copyright Terms
    • Authors
    • Deals
  • Info
    • Accommodation
    • Classified Adverts
    • Directory
    • Essential PE Numbers
    • Flight Schedules
    • Forex Converter
    • PE’s Online Radio Stations
      • Algoa FM
      • Bay FM
      • iFM
      • Kingfisher FM
      • MannMade Radio
      • Madibaz Radio
      • Umhlobo Wenene
    • Podcasts
    • Shipping
    • Street Map
    • Tides
    • Ward Details
    • Ward News
    • Weather
  • Contact
    • Advertising on MyPE
  • Submit
    • Blogger
    • 5 Quick PE Questions
    • Entertainment
    • Events
      • Add your Port Elizabeth event
    • Letter to the Editor
    • Lost and Found
    • Movers and Shakers
    • News Article
    • PE Videos
    • Photographs
    • Recipes
    • Traffic Hooligan
    • Say NO
  • Dam Levels
  • Advertorial
  • Business
  • NMBRA
  • NMB Rates
MyPE

MyPE

Community Business Directory, Event Listings, News and Views from Gqeberha, Nelson Mandela Bay

Vaccines show signs of preventing serious illness, says SAHPRA

26 June 2021 By Alan Straton

While breakthrough COVID-19 infections have been recorded in vaccinated individuals, signs are beginning to emerge that inoculations were reducing the risk of serious illness and hospitalisation.

This was on Thursday revealed by South African Health Products Regulatory Authority (SAHPRA) chairperson, Professor Helen Rees, during a webinar on the process of vaccine approval.

The authority’s mandate is to ensure that all health products comply with regulatory principles of safety, quality and efficacy. This includes medical devices, complementary medicines, and veterinary and human medicines.

Despite breakthrough infections, it was critical for the country to obtain and distribute as many jabs as possible.

The country last week entered into the third wave of the COVID-19, with new infections reaching 17 493 on Wednesday.

“Although we are seeing breakthrough infections, it would appear if we look at the (unpublished) J&J data; it does appear that although we are seeing breaks [in] infections many of those infections is mild to moderate disease. In fact we are seeing a reduction in severe disease.”

This, she said, was also the trend with the Pfizer vaccine.

SAHPRA is also monitoring development and experiences around the world.

“But because we have the Beta variant – which we share with many other African countries – South Africa’s in an unfortunate position, but at an important position in that we can generate this data to look at breakthrough infection in the context of this particular variant.”

She reiterated that it was important for the country to obtain and distribute as many vaccines as it possibly can.

“Because if we can reduce the severity of disease, take that terrible burden off the hospitals and we’ll reduce the access mortality [which] will come with that surge of infection and serious diseases,” Rees said.

“So the question is ‘why are we still continuing to immunise?’ Well, the first thing to say is that with a new disease like this, all of these vaccines are brand new, so when you approve [vaccines] what you have is varying degrees or clinical data that tell you how effective the vaccine is likely to be.”

Among the authority’s challenges, is that South Africa has had relatively little clinical data.

“There is some… clinical data about how some of the vaccines perform in the context of the Beta (dominant) variant, but it’s limited, at best. So we have to go on the cumulative knowledge that we have from laboratories data about antibodies and about the clinical data.”

Even if the Johnson & Johnson and Pfizer vaccines – jabs currently in use in the country – were not effective in preventing middle to moderate disease, it was hoped they would avert severe illness and hospitalisation.

National strategy

“We also know that every single vaccine has been rendered less effective in the context of the variant. What we are doing is that we are monitoring these breakthrough infections. There’s a national strategy to look at the breakthrough infections and to evaluate them.

The strategy evaluates if the affected person has had a vaccine, and if yes, which vaccine.

“Secondly, does the person have other comorbidities? Who is this person? Are they over 60? Do they have any other risk factor? Thirdly, what is the severity of the disease? Is it middle, moderate or severe? Are they hospitalized?” she remarked.

The authority was increasingly looking at which virus had caused the breakthrough infection.

SAHPRA Pharmacovigilance Commitee chairperson, Proffesor March Blockman concurred with Rees, saying early data was showing “good” vaccine efficacy, which is often very important”.

“For me it is absolutely critical – 100% efficacy against severe disease [is needed] because that means going to hospital and requiring oxygen,” he said.

Blockman added that at this moment in time, the two vaccines are highly effective against serious disease from COVID-19.

“However, it’s a pandemic and a roll out must occur and we must continue to accumulate data to make sure that it continues to be consistent,” he said. – SAnews.gov.za

Go On – Share the Gqeberha Love!

Gqeberha’s Latest News and Events can be accessed on MyGqeberha.com.

The following two tabs change content below.
  • Bio
  • Latest Posts
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Alan Straton

Chief Cook, Bottle Washer and Broom Mechanic at MyPE
Passionate about Port Elizabeth and definitely NOT packing for Perth. Alan's ethos is epitomised in the words of Nelson Mandela; "I have fought against white domination and I have fought against black domination. I have cherished the idea of a democratic and free society. If need be, it is an ideal for which I am prepared to die." See more articles by Alan.
My Twitter profileMy Facebook profileMy Google+ profileMy LinkedIn profileMy Flickr profileMy Pinterest profile

Latest posts by Alan Straton (see all)

  • Can Too Much Screen Time Increase Childhood Obesity? - 20 November 2026
  • Chilla Brings Mango, Watermelon and Blueberry Bubble Tea to South Africa - 20 November 2026
  • Short Festive Runs Still Need Readable Batch Codes, Says Pinetown Coding Ink Supplier - 20 November 2026
  • Africa Exhibitions Brings Freestanding Heritage Shows to Libraries and Museums Where Walls Stay Untouched - 20 November 2026
  • Pretoria East Renal Clinic Publishes a What-to-Bring List for Specialist and Dialysis Visits - 20 November 2026

Filed Under: Community Tagged With: MyGqeberha

Footer

RSS Straton Electrical

  • Open Cycle Gas Turbine Usage
  • Flattening the curve – What Every Solar Installer Needs to Know
  • Why you shouldn’t leave a charger plugged in when not in use
  • How do I check if an Electrician is properly registered in South Africa?
  • Easy Electrical Troubleshooting for Humans
  • Water – If You Cannot Measure It Then You Cannot Manage It
  • Tips To Survive Loadshedding
  • Eskom’s Top 50 Electricity Saving Tips

RSS MyPE Business News

  • NMBBC On Budget 2025
  • Leading Business Minds Set to Headline Chambers Annual General Meeting
  • Bay of Opportunity Portal
  • Bay of Opportunity Ambassadors Programme to Promote the Bay and Attract Investment
  • 6 Decades of Trucking
  • Thermal Camera Installed at Redhouse Substation
  • Finalist in the 2025 South African Car of the Year
  • Joining hands to create a lasting impact to St Albans Primary School

RSS MyPR Press Releases

  • Can Too Much Screen Time Increase Childhood Obesity?
  • When Logistics Tech Fails, Who Keeps Freight Moving?
  • Grand Theft Auto VI Takes Over Johannesburg With an Immersive Album Listening Experience and Supercar Meet
  • Fatso 98 Closes Out 2026 With Intimate New EP Before I Leave
  • Short Festive Runs Still Need Readable Batch Codes, Says Pinetown Coding Ink Supplier

How you may use MyPE content © 2026 MyPE · Gqeberha, South Africa | Privacy Policy | MyPE Ads and Media Kit